
Nevro Investor Relations Material
Latest events

Q3 2024
Nevro

Q4 2024
4 Mar, 2025

M&A Announcement
6 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nevro Corp
Access all reports
Nevro Corp. is a medical device company specializing in developing and commercializing solutions for the treatment of chronic pain. The company’s primary product is the Senza spinal cord stimulation (SCS) system, which utilizes proprietary high-frequency technology to manage pain without causing paresthesia. The company is headquartered in Redwood City, California, and its shares are listed on the NYSE.
Key slides for Nevro Corp


Q2 2024
Nevro Corp


Q3 2024
Nevro Corp
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
NVRO
Country
🇺🇸 United States